The RDIF and Gamaleya National Research Institute of Epidemiology and Microbiology website on the “Sputnik V” vaccine was visited from 188 countries in its first 24 hours

Press release, 12.08.2020

Moscow, August 12, 2020 –The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, has seen strong international interest in information on “Sputnik V” - Russia’s first vaccine against COVID-19. In its first 24 hours the website about the vaccine at was visited by users online from 188 countries.

Among the requests received on the website were proposals for joint production and distribution of the vaccine as well as offers to become volunteers in vaccine trials.

On August 11, the vaccine developed by the Gamaleya National Research Institute of Epidemiology and Microbiology was registered by the Ministry of Health of Russia and became the world’s first registered vaccine against coronavirus. Full-scale production of the vaccine is expected to begin in September.

The website contains information about the development history of the Russian vaccine against coronavirus, how the vaccine - based on an adenoviral vector – operates, the technological platform of the vector, immunogenicity, safety and other aspects.


Russian Direct Investment Fund (RDIF) is Russia's sovereign wealth fund established in 2011 to make equity co-investments, primarily in Russia, alongside reputable international financial and strategic investors. RDIF acts as a catalyst for direct investment in the Russian economy. RDIF’s management company is based in Moscow. Currently, RDIF has experience of the successful joint implementation of more than 80 projects with foreign partners totaling more than RUB1.9 tn and covering 95% of the regions of the Russian Federation. RDIF portfolio companies employ more than 800,000 people and generate revenues which equate to more than 6% of Russia’s GDP. RDIF has established joint strategic partnerships with leading international co-investors from more than 18 countries that total more than $40 bn. Further information can be found at

For additional information contact:

Arseniy Palagin                                       Andrew Leach / Maria Shiryaevskaya
Russian Direct Investment Fund                        Hudson Sandler
Press Secretary                                        Tel: +44 (0) 20 7796 4133 
Tel: +7 495 644 34 14, ext. 2395
Mobile: +7 916 110 31 41